SUNNYVALE, Calif. , April 26, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the submission of its 510(k) premarket notification with the Food and Drug Administration ( FDA ) for the company's Radixact™ Treatment Delivery System.
Achieves 8% year-over-year revenue growth; Generates $5.4 million of operating income SUNNYVALE, Calif. , April 26, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2016 .
Leading Oncology Specialists Discuss Best Practices and Innovations in Cancer Treatment SUNNYVALE, Calif. , April 22, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO™) Users' Meeting was held April 10 – 11, 2016 at the
SUNNYVALE, Calif. , April 6, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2016 on April 26, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Patients Benefit from Fewer Treatment Sessions and Minimal Side Effects SUNNYVALE, Calif. , March 31, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that MedStar Georgetown University Hospital in Washington, D.C. treated its 1,000th prostate cancer patient with the
SUNNYVALE, Calif. , Feb. 24, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Joshua H. Levine , President and Chief Executive Officer, is scheduled to present at the 36th Annual Cowen and Company Health Care Conference in Boston, MA on Monday, March 7, 2016 at 3:20pm
Record Revenues Achieved as Commercial Execution Continues; Management Reaffirms Fiscal 2016 Guidance SUNNYVALE, Calif. , Jan. 28, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2015 .
SUNNYVALE, Calif. , Jan. 19, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that between January 11 and January 15, 2016 , the company, in privately-negotiated transactions, had repurchased approximately $63.4 million in aggregate principal amount of its 3.75% Convertible
Premier Qatar, Latvian Cancer Centers to Offer Patients Treatment with the CyberKnife® System; Leading Bulgarian Hospital to Provide Treatment with the TomoTherapy® System SUNNYVALE, Calif. , Jan. 14, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the first centers in
SUNNYVALE, Calif. , Jan. 12, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has closed a $70 million straight debt financing agreement with Cerberus Business Finance, LLC , an affiliate of Cerberus Capital Management, L.P.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
